Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sriwahana Adityakarta Tbk. (SWAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sriwahana Adityakarta Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sriwahana Adityakarta Tbk. diperdagangkan di Rp16 (kapitalisasi pasar 48,31 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 2,2× kapitalisasi pasar Sriwahana Adityakarta Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SWAT | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 48,31 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sriwahana Adityakarta Tbk.
PT Sriwahana Adityakarta (the Company) was established on July 2, 1990 by Notarial DeedNo. 1 of Ruth Karliena, S.H., notary in Surakarta.
Selengkapnya di halaman SWAT →
